BEDMINSTER, N.J. -- NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28Rare Disease Day aims to call attention

read more>>

Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosisThe study, which provides further impetus for the integration of TB and HIV services, lays to

read more>>

CHESHIRE, Conn. & SMITHFIELD, R.I. -- Alexion Pharmaceuticals, Inc., (Nasdaq: ALXN) has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010Rare Dise

read more>>

DANA POINT, CA -- The Global Genes Project (www.globalgenesproject.org), today announced that its rare disease campaign slogan, “Hope It’s In Our Genes ,” has been translated into multiple international languages and Braille by rare disease patient advocates and supporters from T

read more>>

BETHESDA, Md. -- The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosisThe drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $

read more>>

ANNAPOLIS, Md. -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services (HHS), through the Biomedical Advanced

read more>>

RALEIGH, N.C. -- After a devastating loss of their five month old son to a genetically linked disease, a North Carolina couple finds hope for a healthy baby through an innovative technology called Preimplantation Genetic Diagnosis (PGDUsing embryo biopsy, PGD allows geneticists to screen for disor

read more>>

PARIS- "Patients and Researchers: Partners for Life- 28 February Marks the Third Rare Disease DayFor this annual event hundreds of patient groups and their partners organise activities to raise awareness on rare diseases and the 30 million people affected by them in EuropeRare Disease Day was l

read more>>

ANNAPOLIS, Md. -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that new data from the Company's Valortim® anthrax anti-toxin program were presented at the 8th Annual ASM Biodefense and The d

read more>>

NEW YORK -- Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher's Gui

read more>>